Mental Health “Mental health is currently a major problem in China, and will become an ever greater problem unless effective interventions are put in place.”   Mental Health has Long Been a Serious Problem in China   The most populous nation in the world is said by some to be “in the…

Pricing Generic drugs foster competition in the pharmaceutical market. Chester “Chip” Davis, Jr.  of the Association for Accessible Medicines (AAM) reveals the data behind generic competition and elaborates on opportunities for further savings.    The American public is clamoring for systemic changes to address skyrocketing drug prices. Specialty drugs—a growing category…

Sweden Sweden is considered a world leader in technology, and its innovative electronic health records system is in high demand by international researchers. Two key leaders of multinational pharma companies in Sweden share how their companies are leveraging digital technology to empower patients.   We know that startups are developing the…

Medical Cannabis Thailand has recently gained a new status as the first Asian country to legalise medical cannabis for medical treatment and research. In a sweeping move, the Thai parliament voted unanimously in favor of its legalisation in November 2018, with the bill then signed into law in early 2019.    Starting…

Thailand Thailand boasts one of the most attractive business and investment environments in the ASEAN region, and pharmaceutical companies implanted in the country benefit from a highly-skilled workforce and enabling infrastructure. Despite some areas in which the country can improve, as well as a degree of political uncertainty, experts still have…

Sweden Some of the key stakeholders in Swedish healthcare and life sciences outline why they feel Sweden’s capital, Stockholm, is a rising star in life sciences innovation.   The Stockholm region is one of the most innovative life sciences hubs in the world Irene Svenonius, Region Stockholm Stockholm, a city built…

Sweden Sweden is aiming to become a leading innovation nation in the life sciences, with the creation of a Life Sciences Office showing that the sector is right at the top of the Nordic nation’s political agenda.   Today, life science is the only sector for which an official government office…

Thailand Thailand is becoming an increasingly attractive location for pharma companies to conduct clinical trials, with multinationals such as Novo Nordisk and Boehringer Ingelheim conducting more and more of their global trials in the country.   We are very active in engaging Thai doctors and patients in benefiting from involvement in…

Cannabis Five of the key emerging trends in the booming global medical cannabis and cannabinoid medicine industries.   Increasing Acceptance The reappearance of cannabis as a tool in our therapeutic toolbox comes at an important time when we have not witnessed any real advances in pharmacological pain management in decades Mark…

Sweden Swedish biotech BioArctic, in collaboration with Japanese firm Eisai, has seen positive Phase IIb results for its BAN2401 antibody – potentially the first disease-modifying treatment for Alzheimer’s Disease and the next global blockbuster.   The results from the Phase IIb study strengthen BioArctic’s belief that BAN2401’s unique binding profile is…

Thailand Diabetes affects more than eight percent of the Thai population, a number that is on the rise, and nearly half of these cases remain undiagnosed. In light of this epidemic, local diabetes associations and multinational pharma companies based in Thailand are coming together to provide awareness, education, and support to…

Egypt In our latest Healthcare & Life Sciences Review, we look at Egypt. With a swathe of economic reforms in the pipeline, including the launch of the Universal Healthcare Act, which aims to provide health coverage to all of Egypt’s 98 million inhabitants, as well as various national campaigns aimed at…